Dichoptic Therapy (e.g., RevitalVision, AmblyoPlay)

Type: procedure

Status: FDA Cleared (some platforms)

Developer: Various companies (e.g., NovaSight, CureSight)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026